ClinicalTrials.govpublic full text
Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
diabetes mellitus, iron metabolism disorders, gastroduodenal ulcer, optic atrophy, sensorineural hearing loss, platelet dysfunction
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 201683
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.